Content Inside :
Theory of IP approach
* High IP concentration of drug
* Longer half-life of drug in abdominal cavity than with IV administration
* Prolonged systemic exposure
* Dedrick R et al, Cancer Treat Rep 1978
Clinical settings evaluated
* Intraoperative at time of primary or secondary surgery (+/- hyperthermia)
* Post-operative in advanced disease
o Optimally & suboptimally debulked
* Adjuvant for early-stage disease
* Consolidation
* After neo-adjuvant chemo + surgery
Potential IP approaches
* Standard chemotherapeutic agents
* Radioactive agents (e.g, P32, AU198)
* Immunologic agents
o Radio-labeled antibodies
o Cytokines (interferon, etc)
o Tumor-infiltrating lymphocytes
My be you need full description for PPT : Intraperitoneal therapy in ovarian cancer, you can download this PPT : Intraperitoneal therapy in ovarian cancer or online view this PPT : Intraperitoneal therapy in ovarian cancer document. This PPT : Intraperitoneal therapy in ovarian cancer powerpoint presentation available from category Cancer. Download Seminar Paper Powerpoint Presentation PPT : Intraperitoneal therapy in ovarian cancer PPT slide and get information about PPT : Intraperitoneal therapy in ovarian cancer.
Category : Cancer